I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 23% ± 7% | |
| fibroblast | 5 studies | 18% ± 1% | |
| pericyte | 4 studies | 18% ± 2% | |
| GABAergic neuron | 4 studies | 26% ± 9% | |
| glutamatergic neuron | 4 studies | 30% ± 12% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 4% | |
| neuron | 4 studies | 23% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 3% | |
| smooth muscle cell | 3 studies | 17% ± 1% | |
| B cell | 3 studies | 20% ± 2% | |
| epithelial cell | 3 studies | 36% ± 1% | |
| natural killer cell | 3 studies | 18% ± 2% | |
| ciliated cell | 3 studies | 25% ± 2% | |
| astrocyte | 3 studies | 20% ± 3% | |
| abnormal cell | 3 studies | 20% ± 5% | |
| interneuron | 3 studies | 25% ± 13% | |
| oligodendrocyte | 3 studies | 23% ± 2% | |
| naive B cell | 3 studies | 18% ± 1% |
